Atrial Fibrillation Trial, Recruiting NCT06906432 Sponsor: Beijing Tiantan Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06906432
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older at the time of joining the trial
  • People who have had a confirmed bleed in the brain (shown by a brain scan such as a CT or MRI) within 48 hours of symptoms starting
  • People who are able to give consent themselves, or who have a legally recognised representative willing to give consent on their behalf

Who may not be able to join:

  • People who are unwilling to participate or are unable to give consent and have no legal representative to do so on their behalf
  • People with a significant heart condition — such as a previous heart attack, heart failure, or irregular heartbeat — unless that condition is stable and well managed
  • People who have had heart bypass surgery, a stent placed, or another heart-related procedure within the past 6 months
  • People who have an active brain tumour, have had a stroke caused by a blocked blood vessel within the past 3 months, or have a history of a previous brain injury that could affect the study results
  • People who have an active cancer, a serious inflammatory or infectious illness, or who have had any surgery within the past 3 months
  • People whose overall health or circumstances would make participation unsafe or not practical, as judged by the trial doctor

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 December 2034

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Short-term cardiac events; Long-term cardiac events; Short-term delayed cerebral ischemia; Long-term delayed cerebral ishemia; Short-term brain-heart syndrome; Long-term brain-heart syndrome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov